These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29460236)

  • 41. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: Insights from continuous monitoring in rhythm control.
    Lin PL; Huang CC; Wu YJ; Su MI; Chiou WR; Liu LY; Liao FC; Lai E; Chen CY; Kuo JY; Lee YH
    J Cardiovasc Electrophysiol; 2019 Feb; 30(2):178-182. PubMed ID: 30575199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value.
    Ford JW; Milnes JT
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):105-20. PubMed ID: 18670369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.
    Kowey PR; Reiffel JA; Ellenbogen KA; Naccarelli GV; Pratt CM
    JAMA; 2010 Dec; 304(21):2363-72. PubMed ID: 21078810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables.
    Quirino G; Giammaria M; Corbucci G; Pistelli P; Turri E; Mazza A; Perucca A; Checchinato C; Dalmasso M; Barold SS
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):91-8. PubMed ID: 19140918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fast atrial activity predicts recurrence of atrial fibrillation after pulmonary vein isolation: results from a prospective randomized study.
    Kriatselis C; Kaufmann J; Nedios S; Liu J; Gerds-Li JH; Fleck E
    J Interv Card Electrophysiol; 2015 Mar; 42(2):101-6. PubMed ID: 25591723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE; Baquero GA; Nickolaus MJ; Wolbrette DL; Kelleman JJ; Samii S; Grando-Ting J; Penny-Peterson E; Davidson WR; Young SK; Naccarelli GV; Gonzalez MD
    Congenit Heart Dis; 2014; 9(3):221-7. PubMed ID: 23947935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kv1.5 Inhibitors for Treatment of Atrial Fibrillation: A Tradeoff between Selectivity and Non-selectivity.
    Guo X; Chen W; Sun H; You Q
    Curr Top Med Chem; 2016; 16(16):1843-54. PubMed ID: 26975505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study).
    Yamashita T; Ogawa S; Sato T; Aizawa Y; Atarashi H; Fujiki A; Inoue H; Ito M; Katoh T; Kobayashi Y; Koretsune Y; Kumagai K; Niwano S; Okazaki O; Okumura K; Saku K; Tanabe T; Origasa H;
    Circ J; 2009 Jun; 73(6):1020-7. PubMed ID: 19359813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients.
    Zhang H; Pan C; Zhang J; Zhu LL; Huang K; Zhong Y; Hu ZY
    Chin Med J (Engl); 2016 Sep; 129(18):2143-8. PubMed ID: 27625082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation.
    Murgatroyd FD; Gibson SM; Baiyan X; O'Nunain S; Poloniecki JD; Ward DE; Malik M; Camm AJ
    Circulation; 1999 Jun; 99(21):2765-70. PubMed ID: 10351970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized trial of budiodarone in paroxysmal atrial fibrillation.
    Ezekowitz MD; Nagarakanti R; Lubinski A; Bandman O; Canafax D; Ellis DJ; Milner PG; Ziola M; Thibault B; Hohnloser SH;
    J Interv Card Electrophysiol; 2012 Jun; 34(1):1-9. PubMed ID: 22205496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.
    Takii E; Inage T; Yoshida T; Ohe M; Gondo T; Haraguchi G; Ito S; Kumanomido J; Imaizumi T; Fukuomoto Y
    Heart Vessels; 2016 Mar; 31(3):402-7. PubMed ID: 25787020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A
    Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
    Yamashita T; Inoue H; Okumura K; Kodama I; Aizawa Y; Atarashi H; Ohe T; Ohtsu H; Kato T; Kamakura S; Kumagai K; Kurachi Y; Koretsune Y; Saikawa T; Sakurai M; Sato T; Sugi K; Nakaya H; Hirai M; Hirayama A; Fukatani M; Mitamura H; Yamazaki T; Watanabe E; Ogawa S;
    Europace; 2011 Apr; 13(4):473-9. PubMed ID: 21148662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.